Developing countries are losing between $20 billion to $40 billion every year, making graft the greatest obstacle to economic and social development around the world, according to a report released this month by the United Nations Office on Drugs and Crime (UNODC).
Entries in Serbia (3)
The SEC said Pfizer's employees and agents paid bribes in Bulgaria, China, Croatia, Czech Republic, Italy, Kazakhstan, Russia, and Serbia. Improper payments went to foreign officials 'to obtain regulatory and formulary approvals, sales, and increased prescriptions for the company’s pharmaceutical products.'
U.K.-based pharma AstraZeneca said its office in Belgrade, Serbia was served with a criminal indictment 'relating to allegations that local employees . . . made allegedly improper payments to physicians at the Institute of Oncology and Radiology of Serbia.'